Molecular Insight into the Inhibitory Mechanism of Galangin Towards Human Cytochrome P450 1A2. A Modeling Study

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 216-222

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling of Cytochrome P450 and Drug Metabolism

By  

Current Drug Metabolism, Vol. 11, Iss. 4, 2010-05 ,pp. : 342-346

Bentham Science Publishers

Access to resources Recommend Favorite

Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction

By  

Current Drug Metabolism, Vol. 10, Iss. 4, 2009-05 ,pp. : 420-432

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Models for Predicting Interactions with Cytochrome p450 Enzyme

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 15, 2006-08 ,pp. : 1609-1618

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Cardiac and Hepatic Cytochrome P450 Enzymes During Heart Failure

By  

Current Drug Metabolism, Vol. 9, Iss. 2, 2008-02 ,pp. : 122-128

Bentham Science Publishers

Access to resources Recommend Favorite